171 related articles for article (PubMed ID: 27515495)
1. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.
Huang EC; Tomic MM; Hanamornroongruang S; Meserve EE; Herfs M; Crum CP
Mod Pathol; 2016 Dec; 29(12):1501-1510. PubMed ID: 27515495
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
4. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
Sagasta A; Castillo P; Saco A; Torné A; Esteve R; Marimon L; Ordi J; Del Pino M
Mod Pathol; 2016 Jan; 29(1):51-9. PubMed ID: 26541274
[TBL] [Abstract][Full Text] [Related]
5. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
6. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
Mills AM; Paquette C; Terzic T; Castle PE; Stoler MH
Am J Surg Pathol; 2017 Feb; 41(2):143-152. PubMed ID: 27680604
[TBL] [Abstract][Full Text] [Related]
7. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
9. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
10. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of p16
Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
[TBL] [Abstract][Full Text] [Related]
12. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M; Parra-Herran C; Howitt BE; Laury AR; Nucci MR; Feldman S; Jimenez CA; McKeon FD; Xian W; Crum CP
Am J Surg Pathol; 2013 Sep; 37(9):1311-8. PubMed ID: 24076771
[TBL] [Abstract][Full Text] [Related]
13. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
14. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
Solano FJ; Rush DS; Wilkinson EJ
Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
[TBL] [Abstract][Full Text] [Related]
18. p16 Expression and Biological Behavior of Flat Vulvar Low-grade Squamous Intraepithelial Lesions (LSIL).
Lewis N; Blanco LZ; Maniar KP
Int J Gynecol Pathol; 2017 Sep; 36(5):486-492. PubMed ID: 28719486
[TBL] [Abstract][Full Text] [Related]
19. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
20. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]